https://ctv.veeva.com/study/hpv-after-chemoradiotherapy
HPV After chemoRadioTherapy
The HART (HPV After chemoRadiotherapy) study is a prospective multicenter observational trial designed to evaluate the clinical utility of HPV testing in the...
hpvchemoradiotherapy
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-walking-programme-chemoradiotherapy-rectal-cancer-rex
A study looking at a walking programme during chemoradiotherapy for rectal cancer (REx)
This study was to see if a walking programme helped people with rectal cancer. For people who were having chemotherapy and radiotherapy before surgery
a studylooking at
https://adisinsight.springer.com/trials/700319637?error=cookies_not_supported&code=912c5a6a-da68-406b-8006-b325cb6dd596
A multi-stage randomised trial of durvalumab (Medi4736) with chemoradiotherapy with 5-fluorouracil...
It is hypothesised that the known synergistic effects of chemotherapy and radiotherapy are augmented by the addition of further therapies and specifically that
multi stage
https://pure.skku.edu/en/publications/phase-ii-trial-of-concurrent-chemoradiotherapy-with-l-asparaginas/
Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly...
https://ar.iiarjournals.org/content/37/8/4189
Metabolic Rather than Pathological Response to Preoperative Chemoradiotherapy Is a Stronger...
Aim: We investigated which is the stronger predictor, pathological response or metabolic response, for survival outcome in patients treated with neoadjuvant...
rather thanresponse tometabolicpathological
https://pubmed.ncbi.nlm.nih.gov/22382882/?dopt=Abstract
Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer
This preoperative chemoradiotherapy regimen using triplets is feasible but results in moderate toxicity. It is noteworthy that this regimen was associated with...
chemoradiotherapydocetaxelcisplatin
https://adisinsight.springer.com/trials/700392336?error=cookies_not_supported&code=0c949547-9792-414b-96b3-a70a310d62ba
Romiplostim N01 in the Treatment of Refractory Chemoradiotherapy-induced Aplastic Anemia: a...
This study aimed to explore the efficacy and safety of romiplostim N01 in the treatment of relapsed/refractory chemoradiotherapy-induced aplastic anemia
in the
https://cris.maastrichtuniversity.nl/en/publications/report-from-a-consensus-meeting-response-to-chemoradiotherapy-in-/
Report from a consensus meeting: response to chemoradiotherapy in rectal cancer - predictor of cure...
https://researchinformation.umcutrecht.nl/en/publications/decrease-of-physical-fitness-during-neoadjuvant-chemoradiotherapy/
Decrease of physical fitness during neoadjuvant chemoradiotherapy predicts the risk of pneumonia...
physical fitnessthe riskdecrease
https://www.archivesofmedicalscience.com/Case-report-of-chemoradiotherapy-combined-with-immunotherapy-for-liver-metastasis,152106,0,2.html
Case report of chemoradiotherapy combined with immunotherapy for liver metastasis and lymph node...
https://adisinsight.springer.com/trials/700392701?error=cookies_not_supported&code=01b6e41d-8db7-4322-8187-b410021ff83f
Chinese Multicenter Phase II Trial of Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous...
Squamous cell carcinoma (SCC) of the anus is a rare malignancy. For localized anal squamous cell carcinoma , definitive chemoradiotherapy is the standard
https://pure.amsterdamumc.nl/en/publications/preoperative-chemoradiotherapy-but-not-chemotherapy-is-associated/
Preoperative chemoradiotherapy but not chemotherapy is associated with reduced risk of...
but notassociated withpreoperativechemoradiotherapychemotherapy
https://boris-portal.unibe.ch/entities/publication/f85ab725-36d6-467e-a4d5-74b540ba966d
Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally...
BACKGROUND We conducted a randomized, phase II, multicenter study to evaluate the anti-epidermal growth factor receptor (EGFR) mAb panitumumab (P) in...
with or without
https://pubmed.ncbi.nlm.nih.gov/16129366/?dopt=Abstract
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus:...
Preoperative chemoradiotherapy with cisplatin and fluorouracil does not significantly improve progression-free or overall survival for patients with resectable...
followed by
https://ctv.veeva.com/study/postoperative-concurrent-chemoradiotherapy-with-docetaxel-for-high-risk-squamous-cell-carcinoma-of-h
Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of...
This is a non-randomized, phase II, open label study of postoperative concurrent chemoradiotherapy with docetaxel for high-risk squamous cell carcinoma of the...
squamous cell carcinoma
https://repository.icr.ac.uk/items/9f044204-ca40-4171-97ac-82c4caeef44d
Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous...
PURPOSE: TrilynX was a randomized, double-blind, phase III study evaluating the addition of xevinapant (an inhibitor of apoptosis proteins inhibitor) or...
https://pubmed.ncbi.nlm.nih.gov/9219702/?dopt=Abstract
Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the...
In patients with squamous-cell esophageal cancer, preoperative chemoradiotherapy did not improve overall survival, but it did prolong disease-free survival and...
https://www.oncolink.org/oncolink-library/journal-scans/pancreatic-cancer/a-randomized-trial-of-chemoradiotherapy-and-chemotherapy-after-resection-of-pancreatic-cancer
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic cancer |...
OncoLink, the Web's first cancer resource,provides comprehensive information on coping with cancer, cancer treatments, cancer research advances, continuing...
randomized trialchemoradiotherapy
https://pure.psu.edu/en/publications/post-operative-radiotherapy-port-or-chemoradiotherapy-cport-follo/
Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II...
post operative
https://www.epistemonikos.org/en/documents/05ef20364e52985b803e573fd97b5a0cf54d7467
Efficacy of anti-PD-1 antibody combined with neoadjuvant concurrent chemoradiotherapy in the...
https://oncodaily.com/oncolibrary/lung-oncology/osimertinib-laura
Osimertinib After Chemoradiotherapy in Stage III EGFR-Mutated NSCLC: LAURA Redefines the Standard...
Apr 28, 2026 - Osimertinib stage III EGFR-mutated NSCLC: LAURA establishes post-CRT osimertinib with major PFS and CNS benefit.
https://pubmed.ncbi.nlm.nih.gov/35276906/
Weight Loss in Post-Chemoradiotherapy Head and Neck Cancer Patients
Background: Weight loss is well-known among head and neck (HNC) patients during radiotherapy and could continue after the treatment is completed. Weight...
head and neck cancerweight losspostchemoradiotherapypatients